Nearly five years after the Philips Respironics recall reshaped the CPAP market, respondents to a recent HME Newspoll say ...

Almost two full years into its Class I recall of more than 5 million respiratory devices, Philips has wrapped up safety tests covering nearly all of the affected models—and is reiterating its previous ...

In a classic “two steps forward, one step back” situation, just as Philips is aiming to wrap up the repair-and-replace program for the 5.5 million respiratory devices it began recalling two years ago, ...

The US Food and Drug Administration issued a Class I recall Friday, the most serious type of recall, for certain Philips Respironics DreamStation1 CPAP machines. A Class I recall means the FDA has ...

"The court concludes that the Graham complaint does not fall within the 'very limited circumstances' that would establish fraudulent joinder. Philips did not meet its heavy burden to show, as a matter ...

In 2021, polyester-based polyurethane (PE-PUR) foam used in Philips Respironics ventilators, CPAP and BiPAP machines was found to degrade and cause serious health issues or death, leading to a mass ...

The U.S. Food and Drug Administration has updated a recall affecting millions of Philips sleep apnea machines, now saying that they may been linked to at least 561 deaths. The agency, in a statement ...

Philips will halt sales of its bilevel positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) machines under a tentative agreement it reached with the U.S. Food and Drug ...